Viewing Study NCT06134128



Ignite Creation Date: 2024-05-06 @ 7:47 PM
Last Modification Date: 2024-10-26 @ 3:13 PM
Study NCT ID: NCT06134128
Status: RECRUITING
Last Update Posted: 2023-11-18
First Post: 2023-09-18

Brief Title: Compensatory Cognitive Training Via Telehealth for Veterans With Alcohol Use Disorders
Sponsor: Portland VA Medical Center
Organization: Portland VA Medical Center

Study Overview

Official Title: Compensatory Cognitive Training Via Telehealth for Veterans With Alcohol Use Disorders CCT-A
Status: RECRUITING
Status Verified Date: 2023-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: CCT-A
Brief Summary: Most individuals entering treatment for alcohol use disorders AUDs present with cognitive deficits across a range of cognitive domains and these deficits frequently persist for six months or longer following remission Cognitive deficits are associated with increased relapse rates less treatment compliance and poorer treatment outcomes in individuals seeking substance use treatment Despite the high rates of cognitive impairments among adults with AUDs and their negative impact on treatment outcomes current evidence-based treatments for AUDs do not specifically treat or address cognitive symptoms Accessible eg brief manualized delivered via telehealth and effective treatments for adults with AUDs and cognitive deficits are urgently needed

The primary objective of this study is to assess the feasibility and acceptability of a manualized 8-week Compensatory Cognitive Training CCT intervention delivered via telehealth for Veterans in early remission from alcohol use disorder AUD

The investigators hypothesize that Motivationally Enhanced Compensatory Cognitive Training for Addictions ME-CCT-A will be feasible and acceptable in a pilot trial of ME-CCT-A delivered via telehealth
Detailed Description: Motivationally Enhanced Compensatory Cognitive Training for Addictions ME-CCT-A is a manualized group-based behavioral intervention 8 weeks 2 hour per week designed to improve cognitive functioning in Veterans with substance use disorders SUDs and cognitive complaints ME-CCT-A is an adaptation of CCT initially developed by clinicians and researchers at the VA Portland Healthcare System and VA San Diego Healthcare System CCT draws from the empirical and theoretical literature on compensatory strategy training for conditions characterized by cognitive complaints and impairments including mild traumatic brain injury psychosis and mild cognitive impairment ME-CCT-A is a comprehensive treatment in that it addresses multiple types of symptoms and concerns that interfere with recovery from addictions - cognitive impairments neuropsychiatric symptoms and lifestyle patterns that increase risk of cognitive impairment poor health and relapse In addition to training in compensatory cognitive skills ME-CCT-A includes mindfulness practices and motivational interviewing techniques to boost the adoption of lifestyle strategies eg nutrition exercise that improve cognition and overall health ME-CCT-A is designed to be easy to administer and as an adjunct to standard SUD treatment programs While initially designed to be delivered in-person ME-CCT-A can be delivered through virtual platforms with little to no modification of the content and structure of the intervention

Given the high rate of AUDs among Veterans the prevalence of cognitive impairments among those with AUDs and the negative impact of cognitive impairments on treatment outcomes an evidence-based cognitive training intervention that optimally addresses the complex needs of Veterans with AUDs and cognitive impairments is of critical importance This study will allow the investigators to optimize ME-CCT-A for the telehealth format and assess the feasibility and acceptability of the intervention in preparation for a larger-scale pilot randomized control trial

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None